ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

CNTA Centessa Pharmaceuticals PLC

10.075
-0.105 (-1.03%)
Last Updated: 08:38:44
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Centessa Pharmaceuticals PLC CNTA NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
-0.105 -1.03% 10.075 08:38:44
Open Price Low Price High Price Close Price Previous Close
10.19 10.00 10.20 10.18
more quote information »

Recent News

Date Time Source Heading
6/10/202406:13EDGAR2Form 8-K - Current report
6/10/202406:00GLOBECentessa Pharmaceuticals Strengthens Executive Leadership..
5/21/202407:45GLOBECentessa Pharmaceuticals to Participate in Upcoming Investor..
5/13/202415:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/13/202415:23EDGAR2Form 8-K - Current report
5/13/202415:10GLOBECentessa Pharmaceuticals Reports Financial Results and..
5/09/202407:01EDGAR2Form ARS - Annual Report to Security Holders
5/09/202407:00EDGAR2Form DEF 14A - Other definitive proxy statements
4/23/202420:36GLOBECentessa Pharmaceuticals Announces Pricing of $100 Million..
4/23/202415:17GLOBECentessa Pharmaceuticals Announces $100 Million Proposed..
4/22/202406:00GLOBECentessa Pharmaceuticals Announces Open IND for ORX750;..
3/28/202415:28GLOBECentessa Pharmaceuticals Reports Business Highlights and..
2/22/202407:00GLOBECentessa Pharmaceuticals to Participate in TD Cowen’s 44th..
2/09/202406:12EDGAR2Form 8-K - Current report
2/09/202406:00GLOBECentessa Pharmaceuticals to Present Additional 52-Weeks of..
2/02/202416:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202416:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202416:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202416:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202416:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/01/202415:07EDGAR2Form 144 - Report of proposed sale of securities
1/22/202407:00GLOBECentessa Pharmaceuticals to Participate in Upcoming Investor..
1/09/202406:56EDGAR2Form 8-K - Current report
1/02/202418:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/02/202418:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/02/202418:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/02/202418:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/02/202418:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/13/202307:00GLOBECentessa Pharmaceuticals to Present at the 42ⁿᵈ Annual J.P...
12/11/202306:05EDGAR2Form 8-K - Current report
12/10/202311:05GLOBECentessa Pharmaceuticals Announces New Data from an..
11/27/202315:15GLOBEAnaptys Expands Immune Cell Modulator Pipeline with..
11/13/202315:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202315:17EDGAR2Form 8-K - Current report
11/13/202315:05GLOBECentessa Pharmaceuticals Reports Financial Results and..
11/02/202308:09GLOBECentessa Pharmaceuticals to Present Additional 52-Weeks of..
10/31/202307:00GLOBECentessa Pharmaceuticals Announces Dosing of First Subject..
10/30/202307:00GLOBECentessa Pharmaceuticals to Participate in Upcoming Investor..
10/25/202308:49EDGAR2Form 8-K - Current report
10/25/202307:00GLOBECentessa Pharmaceuticals Announces Preclinical Data..
10/03/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/03/202315:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/03/202315:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/03/202315:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/03/202315:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/03/202307:00GLOBECentessa Pharmaceuticals Announces Additions to Senior..
9/22/202315:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/20/202315:02EDGAR2Form 144 - Report of proposed sale of securities
9/01/202315:31EDGAR2Form 144 - Report of proposed sale of securities
8/31/202307:00GLOBECentessa Pharmaceuticals to Participate in the Morgan..

Your Recent History

Delayed Upgrade Clock